Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines.
about
Targeted inhibition of STATs and IRFs as a potential treatment strategy in cardiovascular diseasePhytochemicals for the Management of MelanomaIdentification of STAT1 and STAT3 specific inhibitors using comparative virtual screening and docking validationSTAT inhibitors for cancer therapy.Therapeutic modulators of STAT signalling for human diseasesProgress towards the development of SH2 domain inhibitors.Curcumin induces apoptosis through mitochondrial pathway and caspases activation in human melanoma cells.Hirsutinolide Series Inhibit Stat3 Activity, Alter GCN1, MAP1B, Hsp105, G6PD, Vimentin, TrxR1, and Importin α-2 Expression, and Induce Antitumor Effects against Human Glioma.Relevance of Interferon Regulatory Factor-8 Expression in Myeloid-Tumor Interactions.Curcumin ameliorates neuropathic pain by down-regulating spinal IL-1β via suppressing astroglial NALP1 inflammasome and JAK2-STAT3 signalling.Therapeutic targeting of myeloid-derived suppressor cells involves a novel mechanism mediated by clusterin.Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axisPancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner.Morphoproteomics and biomedical analytics confirm the mTORC2/Akt pathway as a resistance signature and activated ERK and STAT3 as concomitant prosurvival/antiapoptotic pathways in metastatic renal cell carcinoma (RCC) progressing on rapalogs: pathogNutritional control of IL-23/Th17-mediated autoimmune disease through HO-1/STAT3 activationCurcuma Contra Cancer? Curcumin and Hodgkin's Lymphoma.Salidroside reduces renal cell carcinoma proliferation by inhibiting JAK2/STAT3 signaling.Use of Polyphenolic Compounds in Dermatologic Oncology.Curcumin: A new candidate for melanoma therapy?Anticancer effect of salidroside on colon cancer through inhibiting JAK2/STAT3 signaling pathway.Signal transducer and activator of transcription proteins: regulators of myeloid-derived suppressor cell-mediated immunosuppression in cancer.STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.CRM1 is a cellular target of curcumin: new insights for the myriad of biological effects of an ancient spice.Unleashing the immune response against childhood solid cancers.The potential for targeting the STAT3 pathway as a novel therapy for melanoma.FLLL32, a curcumin analog, ameliorates intestinal injury in necrotizing enterocolitis.Curcumin and Melanoma: From Chemistry to Medicine.The Role of Compounds Derived from Natural Supplement as Anticancer Agents in Renal Cell Carcinoma: A Review.Interferon-α adjuvant therapy decreases the recurrence of early clear cell renal cell carcinoma and improves the prognosis of Chinese patients.PAC exhibits potent anti-colon cancer properties through targeting cyclin D1 and suppressing epithelial-to-mesenchymal transition.L61H46 shows potent efficacy against human pancreatic cancer through inhibiting STAT3 pathway.Co-delivery of curcumin and STAT3 siRNA using deformable cationic liposomes to treat skin cancer.Investigation of the effects of curcumin on serum cytokines in obese individuals: a randomized controlled trial.Genome-Wide Inhibition of Pro-atherogenic Gene Expression by Multi-STAT Targeting Compounds as a Novel Treatment Strategy of CVDs
P2860
Q26750725-6DD49EA7-1132-4955-A784-1ECB0D118026Q26766708-6DB06C1B-3A94-4496-99EE-C69AD8D47A04Q28543632-092380B5-23DE-4194-B79F-542370F9B495Q33644206-5D4012AB-E2C4-4C3C-9257-32C6ED95850AQ33684732-8B25766B-CA22-4515-8FB5-11BE1A044E3CQ34581878-A4E354F4-1F5B-497A-92D8-B9C58D0AD1DEQ35281874-286C0DED-E72B-4EEB-80FD-E13C332EFD5FQ35761986-6BCD42F2-0BBA-4AF6-9184-31FE3D29B8EFQ37062216-D0F54DBE-87FA-4972-B2CA-9CCA27DE3A14Q37067714-A5E97721-7202-40B6-932D-369B1E12CFBCQ37089543-BD54F93B-C0F7-40A9-9156-F7B6BD866007Q37200858-E6FFCA0F-A396-4AC8-935A-A0629DC5FF45Q37203714-033C9801-ECCE-46BC-84F1-07031A6967A7Q37520310-45B7C895-7EED-4E3A-B9AD-0B569D2F4978Q37698792-99A6A663-BA50-431D-BC2C-DE0E0949F766Q38199088-682B1AF2-F606-4F8D-87FD-2732C55B5669Q38763934-83506497-2992-43F6-9503-416E9CC0E2D1Q38831160-CC35C245-DF9E-4B81-92BA-E4233F9CE3EDQ38859978-9A76D5E4-0C96-47C8-9164-13C8DC81A86FQ38901701-77F3BD7F-3E72-4DC8-B81C-76A651E54CC4Q38939956-AFBA8FA9-1DFD-4A47-B791-4649F9B56BB0Q39023307-FB0B341D-27E3-482F-A11F-6DC359DF2A6EQ39129924-665058C5-EBA0-4B95-BA74-231D40FD9E58Q39224315-33932B8A-C8D3-4477-85E2-A3DC70C10B03Q39388206-DEA76160-1E31-4ACF-A059-12B5A2EDA51BQ40156995-CA560816-3C04-450A-AC60-52591F070D60Q47210956-80E40B00-A21F-45A2-AC29-A066F9C7E47AQ47664030-C799CE7D-2E92-428A-9A3C-A820F503DFBFQ49184688-4B1EC60F-1C7E-4A7C-86AF-258A5C28F14EQ51499892-8DF52535-60A3-4F63-905A-3049B176BA71Q52614677-0D538C1F-D91C-456B-B117-0FB4979A7495Q52836414-E502A3F4-3E5C-47CE-86A0-C7D837E8C581Q55057905-84AF8BB6-F4E9-4FFB-8181-DC60FF4E596AQ57072670-83AEFEA7-C298-4F4B-B892-21A3D34D411C
P2860
Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines.
description
2012 nî lūn-bûn
@nan
2012 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
name
Structurally modified curcumin ...... inoma and melanoma cell lines.
@ast
Structurally modified curcumin ...... inoma and melanoma cell lines.
@en
type
label
Structurally modified curcumin ...... inoma and melanoma cell lines.
@ast
Structurally modified curcumin ...... inoma and melanoma cell lines.
@en
prefLabel
Structurally modified curcumin ...... inoma and melanoma cell lines.
@ast
Structurally modified curcumin ...... inoma and melanoma cell lines.
@en
P2093
P2860
P921
P1433
P1476
Structurally modified curcumin ...... inoma and melanoma cell lines.
@en
P2093
Chenglong Li
Eric B Schwartz
Gregory B Lesinski
Gregory S Young
James R Fuchs
Jiayuh Lin
Jonathan P Etter
Matthew A Bill
P2860
P304
P356
10.1371/JOURNAL.PONE.0040724
P407
P577
2012-08-10T00:00:00Z